Odde Lab News

A simulator developed by Prof. David Odde and his team was used in a large, placebo-controlled randomized clinical trial published in The Lancet Infectious Diseases. 

The project — which includes Prof. David Odde — reimagines the convergence of architecture and biology to understand how organisms create internal structures.

Irfanullah plans to work on a project in Brazil aimed at applying techniques in machine learning and artificial intelligence to develop affordable and accessible technologies for hepatocellular carcinoma.

Dave shares how disease simulators have the potential to power up the potency of clinical trials, making their chances of success far better than they are today.

The biophysics-based model from Dave and team simulated the disease on a molecular and cellular level so the trial team could screen potential treatments computationally long before they were given to participants. 

Dave and team have found that cancer cells can gravitate toward certain mechanical “sweet spot” environments, providing new insights into how cancer invades the body.

A biophysics-based tumor simulator will be developed by BME faculty, thanks to a P01 grant from the National Cancer Institute.

Ghaidan Shamsan has successfully defended his dissertation, "Mechanical Regulation of Glioma Cell Migration".

Dave is creating a biophysical computer model that simulates COVID-19 on a molecular and cellular level, and tests therapies and vaccines computationally.

he PhD candidate reflects on the highlights of her student experience and shares what she finds exciting about her glioblastoma research.